Search Results

There are 19290 results for: content related to: Population Pharmacokinetic/Pharmacodynamic Modeling to Assist Dosing Schedule Selection for Dovitinib

  1. You have free access to this content
    Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1252–1259, Carlos H. Barrios, David Hernandez-Barajas, Michael P. Brown, Se-Hoon Lee, Luis Fein, Jin-Hwang Liu, Subramanian Hariharan, Bridget A. Martell, Jinyu Yuan, Akintunde Bello, Zhixiao Wang, Rajiv Mundayat and Sun-Young Rha

    Version of Record online : 6 SEP 2011, DOI: 10.1002/cncr.26440

  2. Diagnosis of the performance of the state-specific multireference coupled-cluster method with different truncation schemes

    Journal of Computational Chemistry

    Volume 33, Issue 14, 30 May 2012, Pages: 1285–1303, Uttam Sinha Mahapatra and Sudip Chattopadhyay

    Version of Record online : 15 MAR 2012, DOI: 10.1002/jcc.22960

  3. Clinical experience with sunitinib dose escalation in metastatic renal cell carcinoma

    Asia-Pacific Journal of Clinical Oncology

    Volume 11, Issue 3, September 2015, Pages: e1–e5, Nicola Mitchell, Peter CC Fong and Reuben J Broom

    Version of Record online : 6 JAN 2015, DOI: 10.1111/ajco.12296

  4. You have free access to this content
    Abstracts

    BJU International

    Volume 116, Issue S5, December 2015, Pages: 1–23,

    Version of Record online : 9 DEC 2015, DOI: 10.1111/bju.13365

  5. You have free access to this content
    Abstracts

    BJU International

    Volume 114, Issue S4, October 2014, Pages: 1–18,

    Version of Record online : 21 OCT 2014, DOI: 10.1111/bju.12941

  6. State-specific multireference coupled-cluster theory

    Wiley Interdisciplinary Reviews: Computational Molecular Science

    Volume 3, Issue 2, March/April 2013, Pages: 176–197, Andreas Köhn, Matthias Hanauer, Leonie Anna Mück, Thomas-Christian Jagau and Jürgen Gauss

    Version of Record online : 16 OCT 2012, DOI: 10.1002/wcms.1120

  7. You have free access to this content
    Poster Abstracts

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S5, July 2014, Pages: 31–46,

    Version of Record online : 15 JUL 2014, DOI: 10.1111/ajco.12223_5

  8. You have free access to this content
    Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy

    International Journal of Urology

    Volume 20, Issue 8, August 2013, Pages: 744–755, Kazuhiro Yoshimura and Hirotsugu Uemura

    Version of Record online : 21 MAR 2013, DOI: 10.1111/iju.12147

  9. You have free access to this content
    Abstracts

    BJU International

    Volume 118, Issue S5, December 2016, Pages: 4–30,

    Version of Record online : 17 NOV 2016, DOI: 10.1111/bju.13694

  10. You have full text access to this Open Access content
    Targeting Hyperthermia for Renal Cell Carcinoma Using Human MN Antigenspecific Magnetoliposomes

    Japanese Journal of Cancer Research

    Volume 92, Issue 10, October 2001, Pages: 1138–1146, Masashige Shinkai, Biao Le, Hiroyuki Honda, Kazuhiro Yoshikawa, Kazuhiro Shimizu, Shinsuke Saga, Toshihiko Wakabayashi, Jun Yoshida and Takeshi Kobayashi

    Version of Record online : 22 AUG 2005, DOI: 10.1111/j.1349-7006.2001.tb01070.x

  11. You have free access to this content
    Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era

    International Journal of Urology

    Volume 22, Issue 8, August 2015, Pages: 736–740, Katsunori Tatsugami, Nobuo Shinohara, Tsunenori Kondo, Toshinari Yamasaki, Masatoshi Eto, Tomoyasu Tsushima, Toshiro Terachi, Seiji Naito and on behalf of the Japanese Society of Renal Cancer

    Version of Record online : 18 MAY 2015, DOI: 10.1111/iju.12803

  12. You have free access to this content
    Overall survival in patients with metastatic renal cell carcinoma initially treated with bevacizumab plus interferon-α2a and subsequent therapy with tyrosine kinase inhibitors: a retrospective analysis of the phase III AVOREN trial

    BJU International

    Volume 107, Issue 2, January 2011, Pages: 214–219, Sergio Bracarda, Joaquim Bellmunt, Bohuslav Melichar, Sylvie Négrier, Emilio Bajetta, Alain Ravaud, Vesna Sneller and Bernard Escudier

    Version of Record online : 13 OCT 2010, DOI: 10.1111/j.1464-410X.2010.09707.x

  13. You have free access to this content
    Invited Presentations and Oral Abstracts

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S5, July 2014, Pages: 23–30,

    Version of Record online : 15 JUL 2014, DOI: 10.1111/ajco.12223_4

  14. You have free access to this content
    Current management and future perspectives of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 21, Issue 9, September 2014, Pages: 847–855, Richard Lee-Ying, Renee Lester and Daniel YC Heng

    Version of Record online : 27 MAY 2014, DOI: 10.1111/iju.12502

  15. You have free access to this content
    Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care

    BJU International

    Volume 110, Issue 9, November 2012, Pages: 1289–1300, Axel Bex, Martin Gore, Peter Mulders and Cora N. Sternberg

    Version of Record online : 30 MAR 2012, DOI: 10.1111/j.1464-410X.2012.11100.x

  16. You have free access to this content
    Management of sunitinib adverse events in renal cell carcinoma patients: The Asian experience

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 132–144, Aiping ZHOU

    Version of Record online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01525.x

  17. You have free access to this content
    Abstracts

    BJU International

    Volume 112, Issue S3, November 2013, Pages: 1–17,

    Version of Record online : 23 OCT 2013, DOI: 10.1111/bju.12478

  18. You have free access to this content
    Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma

    BJU International

    Volume 108, Issue 5, September 2011, Pages: 665–672, Ágnes Benedict, Robert A. Figlin, Per Sandström, Ulrika Harmenberg, Anders Ullén, Claudie Charbonneau, Rickard Sandin, Edit Remák, Subramanian Hariharan and Sylvie Négrier

    Version of Record online : 25 JAN 2011, DOI: 10.1111/j.1464-410X.2010.09957.x

  19. You have free access to this content
    Patterns of care for metastatic renal cell carcinoma in Australia

    BJU International

    Volume 116, Issue S3, October 2015, Pages: 36–41, Daphne Day, Yada Kanjanapan, Edmond Kwan, Desmond Yip, Nathan Lawrentschuk, Miles Andrews, Ian D Davis, Arun A Azad, Mark Rosenthal, Shirley Wong, Alice Johnstone, Peter Gibbs and Ben Tran

    Version of Record online : 21 JUL 2015, DOI: 10.1111/bju.13176

  20. You have free access to this content
    Pretreatment assessment of tumor enhancement on contrast-enhanced computed tomography as a potential predictor of treatment outcome in metastatic renal cell carcinoma patients receiving antiangiogenic therapy

    Cancer

    Volume 116, Issue 10, 15 May 2010, Pages: 2332–2342, Kyung Seok Han, Dae Chul Jung, Hyuck Jae Choi, Min Soo Jeong, Kang Su Cho, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee and Jinsoo Chung

    Version of Record online : 11 MAR 2010, DOI: 10.1002/cncr.25019